|Dr. Iain Weir-Jones Ph.D., P.Eng., FGS||Chairman and Chief Exec. Officer||N/A||N/A||N/A|
|Mr. Ibrahim Ghobrial||Chief Financial Officer||9.4k||N/A||N/A|
Med BioGene Inc., a life science company, focuses on the development and commercialization of genomic-based clinical laboratory diagnostic tests for cancer. Its products include the GeneFx Lung, a gene expression-based test for early-stage non-small-cell lung cancer that assists in selecting patients for adjuvant chemotherapy. The company has a collaboration agreement with the University Health Network in Toronto. Med BioGene Inc. was founded in 2002 and is headquartered in Vancouver, Canada.
Med BioGene Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.